<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: New Ideas: Personalized Medicine in the Developing World</title>
	<atom:link href="http://spittoon.23andme.com/2008/04/29/new-ideas-personalized-medicine-in-the-developing-world/feed/" rel="self" type="application/rss+xml" />
	<link>http://spittoon.23andme.com/2008/04/29/new-ideas-personalized-medicine-in-the-developing-world/</link>
	<description>A receptacle for genetic knowledge.</description>
	<pubDate>Wed, 07 Jan 2009 08:25:48 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6</generator>
		<item>
		<title>By: PatrickC</title>
		<link>http://spittoon.23andme.com/2008/04/29/new-ideas-personalized-medicine-in-the-developing-world/#comment-227</link>
		<dc:creator>PatrickC</dc:creator>
		<pubDate>Tue, 29 Apr 2008 22:05:07 +0000</pubDate>
		<guid isPermaLink="false">http://spittoon.23andme.com/2008/04/29/new-ideas-personalized-medicine-in-the-developing-world/#comment-227</guid>
		<description>Hooray!  As a member of a non-European population, I think this is a trailblazing move.  I'd really like to understand how the interpretation of my 23andMe data differs from the prevalent European baseline, and I can't get that data anywhere else.  Kudos to the company's ethos of inclusivity!  I love you guys.

&lt;em&gt;Editor's note: The author of this comment is a partner at New Enterprise Associates, an investor in 23andMe.&lt;/em&gt;</description>
		<content:encoded><![CDATA[<p>Hooray!  As a member of a non-European population, I think this is a trailblazing move.  I&#8217;d really like to understand how the interpretation of my 23andMe data differs from the prevalent European baseline, and I can&#8217;t get that data anywhere else.  Kudos to the company&#8217;s ethos of inclusivity!  I love you guys.</p>
<p><em>Editor&#8217;s note: The author of this comment is a partner at New Enterprise Associates, an investor in 23andMe.</em></p>
]]></content:encoded>
	</item>
</channel>
</rss>
